We constantly hear stories from clients, complaining about how poor some of their Suppliers are and in some cases the complaints are justified - software full of bugs, known problems not being acknowledged (or fixed), failure to provide evidence of compliance during audits, switching less skilled resources for the consultants you expected and so on.
The software and IT industry is no better or worse than any other - there are good Suppliers and less good Suppliers, but in a market such as Life Sciences the use of a less good Supplier can significantly increase the cost of compliance and in some rare circumstances place the safety of patients at risk.
Two years after the publication of GAMP 5 and five years after the publication of the GAMP "Testing of GxP Systems" Good Practice Guide (which leveraged the draft ASTM E2500) the Life Sciences industry is still:
- Struggling to understand how to get the best out of Suppliers,
- Complaining about compliance issues associated with outsourcing.
This is especially true when it comes to defining quality and compliance requirements, so it's no wonder that Life Sciences companies struggle to leverage their Suppliers when they've failed to define what it is that they really expect.
In many cases quality and compliance people are involved in the selection of suppliers too late in the process to add any real value. In some circumstances there is no viable option than going with a 'less good' supplier (for instance, when a new Supplier has a really novel application or service that adds real competitive advantage) but in most cases it is possible to identify any gaps and agree how they should be rectified prior to signing a contract.
However, once a contract is signed it's too late to define quality and compliance requirements without Suppliers claiming that these are 'extras' which are outside the contract. While I've heard Regulated Companies make statements like "as a supplier to the Life Sciences industry you must have known that we'd need copies of your test results" (or whatever it is) you can't rely upon those unstated expectations in a court of law.
The result is that achieving the required quality and compliance standards often costs more that anticipated, either because the Supplier charges extra or the Regulated Company picks up the cost of the additional quality oversight. Very few Life Science's companies have actually achieved the promised cost savings with respect to the outsourcing of IT services, usually because the people driving the contract (purchasing, finance and IT) don't really understand what is required with respect to quality and compliance.
When Business & Decision are engaged in a supplier selection process we tell clients "don't sign the contract until you're happy - that's the best leverage you'll ever have over a Supplier" and it's advice worth repeating here.
At its best, the IT sector is a mature and responsible industry with standards and best practices that can be leveraged to assure that clients requirements are met. It's just a pity that the Life Sciences industry - which prides itself on being in control of most things it does - can't find a way to effectively leverage good practices like GAMP and standards like ISO 9001 and ISO 20000 to select and leverage the best IT Suppliers.
No comments:
Post a Comment